Table 1.

Correlation between CCL2 or SNCG expression and clinicopathologic characteristics in 117 cases

SNCGCCL2
NegativePositivePNegativePositiveP
Gender (male: female)28:2737:250.34132:3324:280.741
Age (y)54.9 ± 11.755.7 ± 10.80.4854.7 ± 11.855.9 ± 10.60.55
Serum CEA level0.004*0.000*
    040324527
    17658
    23719
    3319418
Tumor size (cm)4.9 ± 2.56.15 ± 2.680.01*5.1 ± 2.525.98 ± 2.690.19
Differentiation
    Well470.682560.705
    Moderate46494451
    Poor4664
Depth of invasion0.190.009*
    T1+T2116143
    T314111015
    T430453243
Lymph node involvement0.1110.011*
    N024192815
    N117201324
    N212251423
Stage
    I860.000*1220.000*
    II164137
    III182164
    IV13501548
M0.000*0.000*
    M042124113
    M113501548

NOTE: CEA: 0, ≤15 ng/mL; 1, >15-≤40 ng/mL; 2, >40-≤100 ng/mL; 3, >100 ng/mL.